PDL BioPharma, Inc. Business Combination, Contingent Consideration, Liability, Noncurrent
PDL BioPharma, Inc. had Business Combination, Contingent Consideration, Liability, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2020-06-29
- 2018-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2018-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $19.20M.
- 2018-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $18.90M.
- 2018-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $41.40M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2018-09-30 | $19.20M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $18.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $41.40M 10-Q · filed 2018-05-09 |
| 2018-01-06 | $640.00K 10-Q · filed 2018-11-07 |
| 2018-01-05 | $640.00K 8-K · filed 2020-06-29 |
| 2017-12-31 | $42.00M 10-K · filed 2019-03-15 |
| 2017-09-30 | $45.00M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $44.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $43.60M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $42.65M 10-K · filed 2018-03-16 |
| 2016-09-30 | $48.95M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |